Dr. Laura E. Crocitto, MD

Dr. Crocitto practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Crocitto's NPI, 1053406819, was assigned on October 4, 2006. Dr. Crocitto graduated from Keck School of Medicine of USC in 1989. Dr. Crocitto holds California license G70029.

Dr. Crocitto's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Crocitto's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Crocitto to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crocitto practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Crocitto's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Crocitto is board certified in urology by the American Board of Urology. Dr. Crocitto is licensed in California.

Dmand AI lists enlarged prostate, erectile dysfunction and urinary endoscopy among the conditions Dr. Crocitto treats.

CMS data shows 205 Medicare services from Dr. Crocitto across 4 procedure codes in 2024, for 105 Medicare patients. Medicare paid $15,407 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 105 Medicare patients who saw Dr. Crocitto in 2024. The largest group is 65 to 74, with 61 patients. 71% of them have high cholesterol, and 69% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Crocitto's median patient age at 73, with 7% women.

In 2024, Dr. Crocitto wrote 55 Medicare Part D claims for 39 patients. 100% of them were for generic drugs. CMS names the drug for 48 of them, across 2 drugs with 11 or more claims each, at $463 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Crocitto for performance year 2024, reported as part of a group. Dr. Crocitto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Crocitto, published from 2008 to 2015. 2008 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Biomarkers, Tumor and Prostatectomy. Dr. Crocitto has published most often in J Robot Surg. Dr. Crocitto's most frequent co-authors are Kevin G. Chan, MD, Timothy Wilson, MD and Sarah L. Blair, MD.

Dmand AI links Dr. Crocitto to 1 clinical trial. Conditions studied include Erectile Dysfunction and Sexual Dysfunctions, Psychological.

CMS Open Payments shows 1 general payment to Dr. Crocitto from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $24.

Dr. Crocitto graduated from Keck School of Medicine of USC in 1989.

Dr. Crocitto is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.